How Wegovy and Mounjaro Dose Schedules Compare Online
Online Prescription Comparison: Wegovy and Mounjaro Dose Assessment
Getting an online prescription for either Wegovy or Mounjaro requires the same 3-minute clinical assessment, but understanding their dose differences helps your prescriber make the right recommendation. Wegovy's dose escalation spans 20 weeks total - starting at 0.25mg for weeks 1-4, progressing through 0.5mg, 1mg, 1.7mg, before reaching the 2.4mg maintenance dose. Mounjaro follows a shorter 12-week escalation: 2.5mg for weeks 1-4, 5mg for weeks 5-8, 10mg for weeks 9-12, then 15mg maintenance. Both prescription-only medicines require careful medical screening, which our online assessment covers comprehensively for both options.
The online prescription process evaluates your suitability for both treatments simultaneously, examining BMI requirements, contraindications, and current medications against each drug's profile. Your prescriber reviews whether Wegovy's GLP-1-only mechanism or Mounjaro's dual GIP/GLP-1 action aligns better with your medical history. This comparative approach means you receive personalised treatment selection rather than requesting a specific medication blindly. Our GPhC #9012878 registered pharmacy ensures both options meet the same rigorous dispensing standards once prescribed.
Wegovy and Mounjaro Dose Comparison: Pricing and Value Analysis
Wegovy's 5-dose escalation creates different pricing at each stage: 0.25mg starts at £79.99, 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99. New customers can apply code FIRST40 at checkout, while returning customers use DOSE25 for additional savings. Mounjaro pricing follows its 4-dose structure with different cost points reflecting the dual-hormone mechanism. Both treatments offer bundle options for convenience - our Intro Duo (0.25mg & 0.5mg Wegovy) provides two months' progression for £169.99, while similar Mounjaro starter bundles ensure seamless dose advancement.
The dose comparison reveals different long-term cost profiles between these prescription-only medicines. Wegovy's longer escalation period means more weeks at lower-cost doses before reaching maintenance pricing, while Mounjaro's faster progression to higher doses affects monthly expenditure differently. Our Ultimate Stability Trio for Wegovy 2.4mg provides three months of maintenance supply for £649.99, offering supply security once you've completed dose escalation. Both treatments include the same next-day cold-chain delivery and prescriber support, ensuring value extends beyond pricing to comprehensive care quality.
Clinical Evidence Behind Wegovy and Mounjaro Dose Schedules
The dose comparison between Wegovy and Mounjaro reflects different clinical development programmes and mechanisms of action. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021), with the 2.4mg maintenance dose showing optimal efficacy. Mounjaro's tirzepatide demonstrated its effectiveness through the SURMOUNT trials, with the 15mg maintenance dose representing the highest efficacy tier in their clinical programme.
Both dose escalation schedules were designed to minimise gastrointestinal side effects while achieving therapeutic effectiveness, but the timelines differ based on each medication's pharmacokinetic profile. Wegovy's semaglutide requires the longer 20-week escalation to optimise tolerability, while Mounjaro's tirzepatide reaches maintenance dosing in 12 weeks. These evidence-based dose schedules cannot be modified or accelerated, as they form part of each medication's licensed dosing regimen approved by the MHRA.
How Wegovy Works: Understanding GLP-1 Mechanism in Dose Comparison
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to regulate appetite and food intake. Each dose level in the escalation schedule activates GLP-1 receptors in your brain's appetite centres with increasing intensity, promoting feelings of fullness after smaller meals and reducing food cravings. The progressive dose increases allow your body to adapt to enhanced GLP-1 signalling while minimising potential side effects like nausea or vomiting. This mechanism works alongside a reduced-calorie diet and increased physical activity, with higher doses providing stronger appetite suppression. Understanding this GLP-1-only action helps distinguish Wegovy from Mounjaro's dual-hormone approach when comparing dose options with your prescriber.
Online Ordering Process: Wegovy and Mounjaro Dose Prescription Journey
Our 3-minute online clinical assessment covers eligibility for both Wegovy and Mounjaro doses, examining your BMI, medical history, current medications, and previous weight management attempts. The assessment includes specific questions about gastrointestinal conditions, family history of medullary thyroid carcinoma, and other contraindications relevant to both treatments' dose schedules. Once submitted, our GPhC-registered prescribers review your application within 3 working days (or 24 hours with express service), comparing your profile against both medications' licensing criteria and dose escalation requirements. Upon approval, your chosen treatment ships via next-day cold-chain delivery with temperature monitoring to ensure medication integrity throughout the dose escalation period. This streamlined process eliminates GP appointment delays while maintaining comprehensive medical oversight for both dose comparison options.
Storage and Practical Considerations: Wegovy vs Mounjaro Dose Handling
Both Wegovy and Mounjaro require refrigeration at 2-8°C before first use, but their room temperature storage differs significantly in this dose comparison. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, while Mounjaro pens must be used within 21 days at room temperature, giving Wegovy a storage advantage for travel or lifestyle flexibility. Both use pre-filled pen injectors with dose counters, though the injection volumes differ due to their distinct concentration formulations across the dose ranges. The weekly injection schedule remains consistent for both treatments regardless of dose level, with each pen containing 4 doses for monthly supply. These practical differences in storage and handling can influence your choice between dose options, particularly if you travel frequently or prefer medication flexibility during the escalation period.
Personalised Dose Selection: Tailoring Wegovy and Mounjaro Comparison to Your Needs
The online prescription model allows detailed comparison of how each dose schedule fits your lifestyle, work pattern, and tolerance preferences without pressure from face-to-face consultations. Some patients prefer Wegovy's gentler 20-week escalation if they have sensitive stomachs or previous experience with gastrointestinal side effects, while others favour Mounjaro's faster 12-week progression to reach maintenance dosing sooner. Your prescriber can explain how each dose timeline aligns with your weight management goals, social commitments, and other health priorities through the online consultation process. This personalised approach ensures your chosen treatment integrates seamlessly with your daily routine throughout the dose escalation period.
The dose comparison extends beyond simple scheduling to consider how each medication's mechanism might interact with your existing health conditions, medications, or lifestyle factors. For instance, patients with type 2 diabetes might see different considerations in the dose selection process, while those with demanding work schedules might prioritise the storage flexibility differences between treatments. Our online platform allows thorough exploration of these personalised factors without rushing through a brief GP appointment, ensuring your final dose choice reflects comprehensive consideration of all relevant factors.
Securing Your Prescription: Next Steps for Wegovy and Mounjaro Dose Comparison
Starting your Wegovy and Mounjaro dose comparison today takes just 3 minutes through our online clinical assessment at https://everydaymeds.co.uk/collections/wegovy, where you can explore both treatment options comprehensively. New customers can apply code FIRST40 at checkout for additional savings on either medication choice, while returning customers should use code DOSE25 for continued value. Our GPhC #9012878 registered prescribers ensure every dose recommendation meets the highest safety standards, whether you choose Wegovy's 5-stage escalation or Mounjaro's 4-stage programme. Both prescription-only medicines ship with detailed dose escalation guides, injection training materials, and ongoing clinical support throughout your treatment journey. Remember that both medications work alongside a reduced-calorie diet and increased physical activity, with your prescriber available to adjust recommendations based on your progress through the dose schedules.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
